Literature DB >> 11952856

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

H Ueno1, J Murphy, J R Jass, H Mochizuki, I C Talbot.   

Abstract

AIMS: Although the characteristic of invasive pattern which contributes to Jass's classification is a sensitive prognostic marker in rectal cancer, reproducibility of its assessment has been shown to be problematic. As another histological parameter of invasive margin, we examined the prognostic significance of tumour 'budding' and attempted to establish its appropriate criteria. METHODS AND
RESULTS: A total of 638 rectal cancer specimens was examined. We defined tumour 'budding' as an isolated single cancer cell or a cluster composed of fewer than five cancer cells. We divided these into two groups by their intensity, i.e. the number of 'budding' foci within a microscopic field of x 250. Rectal cancer with high-grade 'budding' (>or= 10 foci in a field) was observed in 30.1% of patients, and was associated with lower 5-year survival rates (40.7%) than patients with low-grade 'budding' (84.0%) (P < 0.0001). Based on multivariate analysis, tumour 'budding' was selected as the significant independent variable, together with the number of nodes involved, extramural spread, lymphocytic infiltration, apical nodal involvement and tumour differentiation. Kappa coefficient of two-graded tumour 'budding' in the intraobserver study was 0.84.
CONCLUSIONS: Because of its value as a prognostic indicator and its reproducibility, tumour 'budding' would be a good index to estimate the aggressiveness of rectal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 11952856     DOI: 10.1046/j.1365-2559.2002.01324.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  186 in total

1.  C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.

Authors:  Ryota Oshiro; Hirofumi Yamamoto; Hidekazu Takahashi; Masahisa Ohtsuka; Xin Wu; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Yuichiro Doki; Masaki Mori
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

Review 2.  Tumour budding in colorectal cancer: what do we know and what can we do?

Authors:  Linde De Smedt; Sofie Palmans; Xavier Sagaert
Journal:  Virchows Arch       Date:  2015-11-27       Impact factor: 4.064

3.  Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Marianne Huebner; Bruce G Wolff; Thomas C Smyrk; Jeremiah Aakre; David W Larson
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

4.  Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Authors:  Jeremy R Jass; Michael J O'Brien; Robert H Riddell; Dale C Snover
Journal:  Virchows Arch       Date:  2006-11-25       Impact factor: 4.064

5.  Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Keiichi Ishikawa; Hajime Fujimoto; Eiji Shinto; Kazuo Hase
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

6.  Interobserver variability amongst gastrointestinal pathologists in assessing prognostic parameters of malignant colorectal polyps: a cause for concern.

Authors:  A Davenport; J Morris; S A Pritchard; E Salmo; M Scott; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2016-08-13       Impact factor: 3.781

7.  Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer.

Authors:  Katarzyna Guzinska-Ustymowicz; Andrzej Kemona
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

8.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

9.  Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

Authors:  Sang-Sik Ha; Hong-Jo Choi; Ki-Jae Park; Jung-Min Kim; Sung-Heun Kim; Young-Hoon Roh; Hyuk-Chan Kwon; Mee-Sook Roh
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

10.  Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition.

Authors:  Raul S Gonzalez; Won Jae Huh; Justin M M Cates; Kay Washington; R Daniel Beauchamp; Robert J Coffey; Chanjuan Shi
Journal:  Histopathology       Date:  2016-10-28       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.